Loading data for EVAX — first visit, this takes a few seconds.
Evaxion A/S (EVAX)
NasdaqCM: EVAX
· リアルタイム株価 · USD
3.15
+0.00 (0.00%)
終値時点: Aug 20, 2026, 8:00 PM
3.28
-0.05%
時間外: 7:59 PM
株価、主要な数字、最新ニュースをひとまとめにしたページです。
Evaxion A/S(EVAX)の株価・分析・データ
0.00% (1D)
データがありません
EVAXについて
Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are...
企業情報の全文決算サプライズ
Evaxion A/SはMay 7, 2026に四半期決算を発表しました:
2ページ中1ページ
